EUVIMEDEUVIMED entdecken
Crossref

Genetically-engineered T cells to treat viral hepatitis-associated liver cancer: is it possible?

Johan Garssen, Juandy Jo

AIMS Allergy and Immunology · 2017

DOI: 10.3934/allergy.2017.1.43 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AIMS Allergy and Immunology, 2017. Verfasst von Johan Garssen und 1 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Garssen, J., & Jo, J. (2017). Genetically-engineered T cells to treat viral hepatitis-associated liver cancer: is it possible?. AIMS Allergy and Immunology. https://doi.org/10.3934/allergy.2017.1.43

Vancouver

Garssen J, Jo J. Genetically-engineered T cells to treat viral hepatitis-associated liver cancer: is it possible?. AIMS Allergy and Immunology. 2017. doi:10.3934/allergy.2017.1.43

BibTeX
@article{Garssen2017,
  author = {Garssen, Johan and Jo, Juandy},
  title = {Genetically-engineered T cells to treat viral hepatitis-associated liver cancer: is it possible?},
  journal = {AIMS Allergy and Immunology},
  year = {2017},
  doi = {10.3934/allergy.2017.1.43}
}
Kostenlos starten →